Skip to main content

American Transplant Congress Announces 2026 Program Featuring Top Voices and Breakthrough Science

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

BOSTON, MA / ACCESS Newswire / April 17, 2026 / The American Transplant Congress (ATC) 2026, the joint annual meeting of the  American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS), will bring together the most influential voices in solid organ and tissue transplantation for a high-impact education program showcasing the latest breakthroughs in scientific and clinical care. Registration for the meeting is open now.

Hosted at the Thomas M. Menino Convention & Exhibition Center, ATC 2026 will feature leading experts from around the world, delivering timely insights across organ-specific medicine, emerging research and the evolving landscape of transplantation. Designed for professionals across disciplines, the program offers a powerful forum for collaboration and discovery.

Built Around the Most Important Topics in Transplantation

The ATC 2026 education program brings together a comprehensive range of sessions addressing the most pressing and promising areas in the field, including:

Precision diagnostics and personalized transplant care

Safely and ethically expanding and optimizing the donor pool

Immunosuppression, sensitization and immune modulation innovation

Ethics and fair access

Systems innovation, workforce sustainability and the future of transplant care

Sessions are organized to reflect how transplant professionals approach their work, by organ system and clinical application, ensuring highly relevant, practice-focused learning.

Nobel Laureates as Headline Speakers

A cornerstone of the ATC education program, State-of-the-Art Lectures will feature Nobel Prize-winning researchers and globally recognized innovators.

Alvin E. Roth, PhD - Nobel Prize-winning economist known for his groundbreaking work in market design, including kidney exchange systems

Drew Weissman, MD, PhD - Nobel Prize-winning physician-scientist whose work on mRNA technology enabled the development of COVID-19 vaccines

These sessions offer a rare opportunity to hear directly from individuals shaping the next era of scientific discovery.

Advancing Science, Saving Lives

ATC 2026 will continue to serve as a premier platform for scientific exchange, featuring podium presentations, emerging discovery oral sessions and poster presentations. All accepted abstracts will be published in an online supplement to the American Journal of Transplantation, reinforcing the meeting's role in advancing global knowledge and research dissemination.

"ATC continues to be the premier destination for transplant professionals seeking high-quality education and meaningful connection with colleagues across the field," said David Foley, MD, FACS, FAST, FAASLD, President of the American Society of Transplantation (AST).

"The 2026 program highlights the cutting edge of transplantation, from breakthrough science to emerging innovations that will shape the future of patient care," said Jim Markmann, MD, PhD, President of the American Society of Transplant Surgeons (ASTS).

Full details on session titles, speakers and scheduling can be found at atcmeeting.org/learn.

###

The American Transplant Congress (ATC) is the Joint Annual Meeting of the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS). The premier event for innovation and progress in transplantation will be held June 20-24, 2026, in Boston, MA. ATC provides a forum for exchange of new scientific and clinical information relevant to solid organ and tissue transplantation. The event brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists, allied health professionals and other transplant professionals.  Learn more at www.atcmeeting.org.

Contact Information

Lauren B Weber
media@atcmeeting.org
703-403-1417

SOURCE: American Transplant Congress



View the original press release on ACCESS Newswire

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.56
+0.86 (0.34%)
AAPL  270.23
+6.83 (2.59%)
AMD  278.39
+0.13 (0.05%)
BAC  53.91
+0.40 (0.75%)
GOOG  339.40
+6.63 (1.99%)
META  688.55
+11.68 (1.73%)
MSFT  422.79
+2.53 (0.60%)
NVDA  201.68
+3.33 (1.68%)
ORCL  175.06
-3.28 (-1.84%)
TSLA  400.62
+11.72 (3.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.